|
||||||||||||||||||||||||||||||||
| SEMINARS / SYMPOSIA | home > public programs > seminars / symposia | |||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
![]() |
![]() Michael Rossman, Ph.D., Purdue University |
|||||||||||||||||||||||||||||||
Structural Biology in the 21st Century - IV |
||||||||||||||||||||||||||||||||
| Thursday, September 18, 2008 Ivan Rayment, Ph.D., University of Wisconsin-Madison "The Structure and Function of Kar3/Vik1: When is a molecular motor not a motor.” |
||||||||||||||||||||||||||||||||
| Thursday, October 2, 2008 David C. Richardson, Ph.D., Duke University "Checking on your Mol's Probity: MolProbity Evaluation for Structure Refinement and Bioinformatics.” |
||||||||||||||||||||||||||||||||
| Thrusday, November 13, 2008 Neil L. Kelleher, Ph.D., University of Illinois “The Biosynthesis of Polyketide and Peptide Natural Products Viewed Through the Lens of High Performance Mass Spectrometry.” |
||||||||||||||||||||||||||||||||
| Thursday, December 11, 2008 Walid A. Houry, Ph.D., University of Toronto “The Multiple Cellular Roles of the Hsp90 Molecular Chaperone.” |
||||||||||||||||||||||||||||||||
| January TBA | ||||||||||||||||||||||||||||||||
| Thursday, February 19, 2009 George N Phillips, Jr., Ph.D., University of Wisconsin-Madison “Protein Crystallography at the Fringes: Limits of the usual Bragg and Debye-Waller approximations.” |
||||||||||||||||||||||||||||||||
| Thursday, March 19, 2009 James Holton, Ph.D., Advanced Light Source, Berkrlry “The threshold of "solvability" in protein crystallography.” |
||||||||||||||||||||||||||||||||
| Thursday, April 16, 2009 John A. Tainer, Ph.D., The Scripps Institute “Small Angle X-ray Scattering (SAXS) combined with crystallographt and computation: defining accurate macromolecular structures in solution.” |
||||||||||||||||||||||||||||||||
Thursday, May 21, 2009 |
||||||||||||||||||||||||||||||||
| Thursday, June 18, 2009 Rachel Klevit, Ph.D., University of Washington "Diversity & specificity in protein ubiquitination: the BRCA1/BARD1 paradigm." |
||||||||||||||||||||||||||||||||